Integrated Serologic Surveillance of Population Immunity and Disease Transmission

Antibodies are unique among biomarkers in their ability to identify persons with protective immunity to vaccine-preventable diseases and to measure past exposure to diverse pathogens. Most infectious disease surveillance maintains a single-disease focus, but broader testing of existing serologic sur...

Full description

Bibliographic Details
Main Authors: Benjamin F. Arnold, Heather M. Scobie, Jeffrey W. Priest, Patrick J. Lammie
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-07-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/24/7/17-1928_article
id doaj-56b6b178690442f6bad870e56e5f9429
record_format Article
spelling doaj-56b6b178690442f6bad870e56e5f94292020-11-24T21:32:42ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592018-07-012471188119410.3201/eid2407.171928Integrated Serologic Surveillance of Population Immunity and Disease TransmissionBenjamin F. ArnoldHeather M. ScobieJeffrey W. PriestPatrick J. LammieAntibodies are unique among biomarkers in their ability to identify persons with protective immunity to vaccine-preventable diseases and to measure past exposure to diverse pathogens. Most infectious disease surveillance maintains a single-disease focus, but broader testing of existing serologic surveys with multiplex antibody assays would create new opportunities for integrated surveillance. In this perspective, we highlight multiple areas for potential synergy where integrated surveillance could add more value to public health efforts than the current trend of independent disease monitoring through vertical programs. We describe innovations in laboratory and data science that should accelerate integration and identify remaining challenges with respect to specimen collection, testing, and analysis. Throughout, we illustrate how information generated through integrated surveillance platforms can create new opportunities to more quickly and precisely identify global health program gaps that range from undervaccination to emerging pathogens to multilayered health disparities that span diverse communicable diseases.https://wwwnc.cdc.gov/eid/article/24/7/17-1928_articleantibodiesimmunologic surveillancecommunicable diseasesemergingvaccinationmalaria
collection DOAJ
language English
format Article
sources DOAJ
author Benjamin F. Arnold
Heather M. Scobie
Jeffrey W. Priest
Patrick J. Lammie
spellingShingle Benjamin F. Arnold
Heather M. Scobie
Jeffrey W. Priest
Patrick J. Lammie
Integrated Serologic Surveillance of Population Immunity and Disease Transmission
Emerging Infectious Diseases
antibodies
immunologic surveillance
communicable diseases
emerging
vaccination
malaria
author_facet Benjamin F. Arnold
Heather M. Scobie
Jeffrey W. Priest
Patrick J. Lammie
author_sort Benjamin F. Arnold
title Integrated Serologic Surveillance of Population Immunity and Disease Transmission
title_short Integrated Serologic Surveillance of Population Immunity and Disease Transmission
title_full Integrated Serologic Surveillance of Population Immunity and Disease Transmission
title_fullStr Integrated Serologic Surveillance of Population Immunity and Disease Transmission
title_full_unstemmed Integrated Serologic Surveillance of Population Immunity and Disease Transmission
title_sort integrated serologic surveillance of population immunity and disease transmission
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2018-07-01
description Antibodies are unique among biomarkers in their ability to identify persons with protective immunity to vaccine-preventable diseases and to measure past exposure to diverse pathogens. Most infectious disease surveillance maintains a single-disease focus, but broader testing of existing serologic surveys with multiplex antibody assays would create new opportunities for integrated surveillance. In this perspective, we highlight multiple areas for potential synergy where integrated surveillance could add more value to public health efforts than the current trend of independent disease monitoring through vertical programs. We describe innovations in laboratory and data science that should accelerate integration and identify remaining challenges with respect to specimen collection, testing, and analysis. Throughout, we illustrate how information generated through integrated surveillance platforms can create new opportunities to more quickly and precisely identify global health program gaps that range from undervaccination to emerging pathogens to multilayered health disparities that span diverse communicable diseases.
topic antibodies
immunologic surveillance
communicable diseases
emerging
vaccination
malaria
url https://wwwnc.cdc.gov/eid/article/24/7/17-1928_article
work_keys_str_mv AT benjaminfarnold integratedserologicsurveillanceofpopulationimmunityanddiseasetransmission
AT heathermscobie integratedserologicsurveillanceofpopulationimmunityanddiseasetransmission
AT jeffreywpriest integratedserologicsurveillanceofpopulationimmunityanddiseasetransmission
AT patrickjlammie integratedserologicsurveillanceofpopulationimmunityanddiseasetransmission
_version_ 1725956480291569664